Sobre 2 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Explore the full record of transactions filed by Pande Atul, Consejero. Director active across 2 companies, notably Karuna Therapeutics, Inc.. Aggregated, 28 disclosures have been published. Breakdown: 2 buys · 5 sells. Total volume traded: €584k. Activity tracked since 1 April 2021. The latest transaction was disclosed on 28 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Pande Atul
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2500 títulos@ 16,00 US$5.2% de su flujoCommon StockSEC:0001593968-21-001919:0
25 de 28 declaraciones
About Pande Atul
Pande Atul is Administrateur of Immunovant, Inc. and Karuna Therapeutics, Inc. He has 24 filings in total. Among the recent filings we hold, they cover the period from 2021-05-03 to 2026-06-26, with buys of EUR 119454 and sells of EUR 657041, and the most common transaction nature is Levée d'options.